Home

Subscription

February 2017 issue

January 2017 issue



BACK ISSUES

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2006


2011 Issues

December 2011 Issue
• "I Never Told Her"
• New Therapeutic Agents Marketed in the United States in 2011 (Table)
• Index for 2011


November 2011 Issue
• Feature - Merchants of Death - Chain Pharmacy CEOs Must Stop the Sale of Cigarettes!
• New Drug Review: Telaprevir (Incivek)


October 2011 Issue
• Feature - Deception and Hypocrisy from Mail-Order Pharmacies
• New Drug Review: Ticagrelor (Brilinta)


September 2011 Issue
• Feature - The Tylenol Follies
• New Drug Review: Rivaroxaban (Xarelto)


August 2011 Issue
• Feature - Drug Shortages - Pharmaceutical Companies Have Caused This Problem and it is Their Responsibility to Resolve It!
• New Drug Review: Lurasidone hydrochloride (Latuda)


July 2011 Issue
• Feature - Express Scripts and Medco - A Fallen Giant or a Bigger Monster?
• New Drug Review: Vilazodone hydrochloride (Viibryd)


June 2011 Issue
• Feature - Pharmacy's Vision for 2015 OR a Large Surplus of Pharmacists?
• New Drug Review: Linagliptin (Tradjenta)


May 2011 Issue
• Feature - Mail-Order Pharmacy Programs - Limitations, Inequities, and Deception
• New Drug Review: Ceftaroline fosamil (Teflaro)


April 2011 Issue
• Feature - The Large Chains are Making a Mockery of our Profession - And our Profession is a Co-conspirator Through our Silence!
• New Drug Review: Azilsartan medoxomil (Edarbi)


March 2011 Issue
• Feature - TobBoth Patients and Health Care Have a Great Need for a Personal Touch!
• New Drug Review: Collagenase clostridium histolyticum (Xiaflex)


February 2011 Issue
• Feature - Priorities for our Profession
• New Drug Review: Pegloticase (Krystexxa)


January 2011 Issue
• Feature - A New Year, an Old Theme - Pharmacy Must Have a More Effective National Organizational Structure!
• New Drug Review: Fingolimod hydrochloride (Gilenya)